Phase 2 Nasopharyngeal Cancer Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2Phase 3
Trop2-targeted immunoPET Imaging of Solid Tumors
Liver CancerOvarian CancerCervical Cancer+11 more
RenJi Hospital400 enrolled1 locationNCT06851663
Recruiting
Phase 1Phase 2
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Lung CancersUrothelial CancerLocally Advanced+5 more
Avenzo Therapeutics, Inc.480 enrolled18 locationsNCT07038343
Recruiting
Phase 2
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
Nasopharyngeal Cancer
National University Hospital, Singapore50 enrolled1 locationNCT05305131
Recruiting
Phase 2
Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based Treatment
Nasopharyngeal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology32 enrolled4 locationsNCT04875611
Recruiting
Phase 2
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Nasopharyngeal CancerNasopharyngeal Carcinoma
Sun Yat-sen University50 enrolled4 locationsNCT06349889
Recruiting
Phase 2
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Nasopharyngeal CancerNasopharyngeal CarcinomaNasopharynx Cancer+1 more
German Society for Pediatric Oncology and Hematology GPOH gGmbH57 enrolled31 locationsNCT06019130
Recruiting
Phase 2
Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT
Nasopharyngeal Cancer
Fudan University198 enrolled1 locationNCT05628922
Recruiting
Phase 2
Gemcitabine and carboplatin induction chemotherapy followed by concurrent cisplatin and IMRT for locally advanced nasopharyngeal cancer
Locally advanced nasopharyngeal cancer
Peter MacCallum Cancer Centre30 enrolled1 locationACTRN12605000509662